Close

Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

×

Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Biohaven appoints SVP of finance

Scuttlebutt | November 14, 2017

Biohaven Pharmaceutical Holding Company and its wholly owned subsidiary, Biohaven Pharmaceuticals, has appointed Scott Phillips as senior vice president of finance. He will focus on further advancing Biohaven's infrastructure to support the company's accounting, external reporting and finance capabilities.

Phillips joins Biohaven, a clinical-stage biopharmaceutical company, with nearly 20 years of accounting and finance experience in both the pharmaceutical industry and public accounting practice. Most recently, he served as chief accounting officer, and then SVP of global business finance, at Alexion Pharmaceuticals. 

At Alexion, Phillips was responsible for expanding the accounting organization and internal control structure from a pre-commercial business to a global accounting organization supporting over 50 countries. In these roles, his responsibilities included overseeing...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.